Affinity purification of insoluble recombinant fusion proteins containing glutathione-S-transferase. 1992

J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
Departments of Medicine, Division of Hematology and Oncology, UAB Station, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.

Prokaryotic expression of polypeptides as fusion proteins with glutathione-S-transferase has recently been reported as a one-step means of purifying recombinant protein. The usefulness of the glutathione-S-transferase/glutathione-agarose system, however, is significantly limited by the frequent synthesis of recombinant proteins in insoluble form by Escherichia coli. We have found that for 5 separate fusion proteins containing glutathione-S-transferase and different domains of the large cystic fibrosis transmembrane conductance regulator, all were packaged in insoluble form by E. coli. Insolubility of these products made them inaccessible to one-step purification utilizing this scheme requires proper folding of recombinant glutathione-S-transferase to allow recognition on glutathione affinity agarose, we investigated the suitability of several alternative approaches for converting insoluble recombinant fusion proteins to a soluble form amenable to glutathione-agarose affinity purification. Low-temperature induction of fusion protein synthesis, but not incubation with anion-exchange resins, led to improved one-step purification of glutathione-S-transferase fusion proteins from E. coli cell lysate using mild, nondenaturing conditions. Solubilization in 8 mol/L urea, but not with other chaotropic agents or detergents, also allowed preparative yields of affinity-purified fusion protein. These techniques increase the usefulness of this recombinant protein purification scheme, and should be broadly applicable to diverse polypeptides synthesized as fusions with glutathione-S-transferase.

UI MeSH Term Description Entries

Related Publications

J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
January 2022, Methods in molecular biology (Clifton, N.J.),
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
May 2001, Current protocols in molecular biology,
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
January 2002, Methods in enzymology,
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
November 1992, Journal of immunological methods,
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
August 1993, Bio/technology (Nature Publishing Company),
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
September 2012, BMC biotechnology,
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
April 1993, Analytical biochemistry,
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
June 2000, Analytical biochemistry,
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
January 2011, Methods in molecular biology (Clifton, N.J.),
J Hartman, and P Daram, and R A Frizzell, and T Rado, and D J Benos, and E J Sorscher
August 2009, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Copied contents to your clipboard!